3-Year outcomes after left atrial appendage closure in patients with nonvalvular atrial fibrillation: cardiomyopathy related with increased death and stroke rate

被引:4
作者
Chen, Chunyu [1 ,2 ]
Chen, Yuyi [1 ]
Qu, Lulu [1 ]
Su, Xi [1 ]
Chen, Yanhong [1 ]
机构
[1] Wuhan Asia Heart Hosp, Dept Cardiol, 753Rd Jinghan Rd, Wuhan 430022, Hubei, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Affiliated Hosp 2, Dept Cardiol, Wuhan 430060, Peoples R China
关键词
Left atrial appendage closure; Device-related thrombus; Non-valvular atrial fibrillation; Stroke; Death; EFFICACY; WATCHMAN; SAFETY;
D O I
10.1186/s12872-023-03054-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionLeft atrial appendage closure (LAAC) is a novel treatment for stroke prevention in high-risk patients with non-valvular atrial fibrillation (NVAF). However, the long-term outcomes after LAAC in Chinese NVAF patients are still lacking.MethodsThis was a single-center, bidirectional, nonrandomized registered study. Patients who underwent LAAC implantation from May 2014 to April 2021 in a large Chinese center were enrolled. The primary endpoint was combined all-cause death and stroke.ResultsFrom May 2014 to April 2021, a total of 673 NVAF patients were enrolled. The overall successful implantation rate was 97.62% (657 of 673). The rate of perioperative adverse events was 1.19% (8 of 673), including 3 cardiac tamponades, 2 ischemic strokes, one device-related thrombus (DRT) and 2 device dislocations. 604 (92.24%) patients completed the follow-up, the median follow-up period was 36.9 months (IQR 24.8-56.5 months). 16 stroke events occurred in 15 patients (one patient suffered from both hemorrhagic and ischemic strokes). 13 patients (2.15%) had ischemic stroke, and the fatal rate was 0.33% (2 of 604). 3 patients (0.15%) suffered from hemorrhagic stroke, and the fatal rate was 0.17% (1 of 604). The overall stroke rate was 0.74% per-year. The combined death and stroke rate was 1.93% per-year. In the multivariate Cox regression analysis, age >= 75 (hazard ratio 2.264, 95% CI 1.074-4.772, P = 0.032) and ventricular cardiomyopathy (hazard ratio 2.738, 95% CI 1.060-7.071, P = 0.037) were independent predictors of combined mortality and stroke.ConclusionThe overall successful implantation rate of LAAC was 97.62% and the rate of perioperative adverse events was 1.19% in this study, and the stroke rate was 0.74% per year during the long-term follow-up. Age >= 75 years and ventricular cardiomyopathy were independent predictors of the primary endpoint.Trial registration This study was retrospectively registered.
引用
收藏
页数:9
相关论文
共 25 条
[1]   Real-world survival data of device-related thrombus following left atrial appendage closure: 4-year experience from a single center [J].
Bai, Yuan ;
Xue, Xin ;
Duenninger, Erich ;
Muenzel, Manuela ;
Jiang, Lisheng ;
Keil, Thorsten ;
Fazakas, Adam ;
Yu, Jiangtao .
HEART AND VESSELS, 2019, 34 (08) :1360-1369
[2]   Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage [J].
Boersma, Lucas V. ;
Ince, Hueseyin ;
Kische, Stephan ;
Pokushalov, Evgeny ;
Schmitz, Thomas ;
Schmidt, Boris ;
Gori, Tommaso ;
Meincke, Felix ;
Protopopov, Alexey Vladimir ;
Betts, Timothy ;
Mazzone, Patrizio ;
Foley, David ;
Grygier, Marek ;
Sievert, Horst ;
De Potter, Tom ;
Vireca, Elisa ;
Stein, Kenneth ;
Bergmann, Martin W. ;
Al Nooryani, Arif ;
Meincke, Felix ;
Fiedler, Thomas ;
Senatore, Gaetano ;
Foley, David ;
Schmidt, Boris ;
Brigadeau, Francois ;
Defaye, Pascal ;
Teiger, Emmanuel ;
Bonnet, Jean-Louis ;
Wald, Christof ;
Schmitz, Thomas ;
Szili-Torok, Tamas ;
Tschishow, Wladimir ;
Mazzone, Patrizio ;
Crossland, David ;
Bergmann, Martin W. ;
Vahanian, Alec ;
Cruz-Gonzalez, Ignacio ;
Thambo, Jean-Benoit ;
Gori, Tommaso ;
Betts, Timothy ;
Al Smadi, Faisal ;
Mudra, Harald ;
Molitoris, Robin ;
Folkeringa, Richard ;
Stevenhagen, Yorick ;
Gras, Daniel ;
De Potter, Tom ;
Tamburino, Corrado ;
Molon, Giulio ;
Protopopov, Vladimir .
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2019, 12 (04)
[3]   Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial [J].
Boersma, Lucas V. ;
Ince, Hueseyin ;
Kische, Stephan ;
Pokushalov, Evgeny ;
Schmitz, Thomas ;
Schmidt, Boris ;
Gori, Tommaso ;
Meincke, Felix ;
Protopopov, Alexey Vladimir ;
Betts, Timothy ;
Foley, David ;
Sievert, Horst ;
Mazzone, Patrizio ;
De Potter, Tom ;
Vireca, Elisa ;
Stein, Kenneth ;
Bergmann, Martin W. .
HEART RHYTHM, 2017, 14 (09) :1302-1308
[4]   Short-term non-vitamin K antagonist oral anticoagulants vs. warfarin in preventing device-related thrombosis after left atrial appendage closure [J].
Chen, Yuyi ;
Zhang, Yonghua ;
Qu, Lulu ;
Huang, Weiping ;
Su, Xi ;
Chen, Yanhong .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (03) :872-879
[5]   Long-term outcomes of percutaneous left atrial appendage closure for the prevention of stroke in patients with atrial fibrillation: Asia-Pacific experience [J].
Chiu, Fu -Chun ;
Huang, Pang-Shuo ;
Chen, Jien-Jiun ;
Hwang, Juey-Jen ;
Tsai, Chia -Ti .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (08) :1442-1449
[6]  
DeSimone Christopher V, 2015, J Atr Fibrillation, V8, P1129, DOI 10.4022/jafib.1129
[7]   The NCDR Left Atrial Appendage Occlusion Registry [J].
Freeman, James, V ;
Varosy, Paul ;
Price, Matthew J. ;
Slotwiner, David ;
Kusumoto, Fred M. ;
Rammohan, Chidambaram ;
Kavinsky, Clifford J. ;
Turi, Zoltan G. ;
Akar, Joseph ;
Koutras, Cristina ;
Curtis, Jeptha P. ;
Masoudi, Frederick A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (13) :1503-1518
[8]   Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries [J].
Holmes, David R., Jr. ;
Reddy, Vivek Y. ;
Gordon, Nicole T. ;
Delurgio, David ;
Doshi, Shephal K. ;
Desai, Amish J. ;
Stone, James E., Jr. ;
Kar, Saibal .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (23) :2878-2889
[9]   Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy [J].
Jung, Hyunjean ;
Sung, Jung-Hoon ;
Yang, Pil-Sung ;
Jang, Eunsun ;
Yu, Hee Tae ;
Kim, Tae-Hoon ;
Pak, Hui-Nam ;
Lee, Moon-Hyoung ;
Joung, Boyoung ;
Lip, Gregory Y. H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (19) :2409-2411
[10]   2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS [J].
Kirchhof, Paulus ;
Benussi, Stefano ;
Kotecha, Dipak ;
Ahlsson, Anders ;
Atar, Dan ;
Casadei, Barbara ;
Castella, Manuel ;
Diener, Hans-Christoph ;
Heidbuchel, Hein ;
Hendriks, Jeroen ;
Hindricks, Gerhard ;
Manolis, Antonis S. ;
Oldgren, Jonas ;
Popescu, Bogdan Alexandru ;
Schotten, Ulrich ;
Van Putte, Bart ;
Vardas, Panagiotis .
EUROPEAN HEART JOURNAL, 2016, 37 (38) :2893-+